These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12906375)

  • 1. Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?
    Stepan JJ
    J Endocrinol Invest; 2003 May; 26(5):458-63. PubMed ID: 12906375
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?
    Seibel MJ
    J Endocrinol Invest; 2003 May; 26(5):464-71. PubMed ID: 12906376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
    Ito M
    Clin Calcium; 2007 Dec; 17(12):1858-64. PubMed ID: 18057661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
    Suzuki A; Sekiguchi S; Asano S; Itoh M
    J Pharmacol Sci; 2008 Apr; 106(4):530-5. PubMed ID: 18431035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 7. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of bone histology in the determination of bone metabolism].
    Barthel HR; Seibel MJ
    Med Klin (Munich); 2003 Feb; 98(2):111-2; author reply 113. PubMed ID: 12638546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical utility of bone markers in the assessment of fracture risk].
    Ichimura S; Satomi K
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():259-63. PubMed ID: 18161116
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of bone turnover markers in the management of osteoporosis.
    Jain S; Camacho P
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):366-372. PubMed ID: 30299435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 12. Office practice of osteoporosis evaluation.
    Lacativa PG; de Farias ML
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):674-84. PubMed ID: 17117293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
    Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
    Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of biochemical markers of bone turnover.
    Seibel MJ
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):603-20. PubMed ID: 17117286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?
    Devogelaer JP; Boutsen Y; Gruson D; Manicourt D
    Rheum Dis Clin North Am; 2011 Aug; 37(3):365-86, v-vi. PubMed ID: 22023897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of osteoporotic fractures: why not apply the evidence?
    Ferrari S
    Swiss Med Wkly; 2008 Nov; 138(45-46):656-7. PubMed ID: 19043812
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone quality: what is it and how is it measured?
    Compston J
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract]   [Full Text] [Related]  

  • 20. [New bone density conservation agents for osteoporosis under research and development: ED-71].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():454-8. PubMed ID: 18161148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.